| For: | Mapouka M, Pabingui E, Tazinkeng NN, Gurmessa M, Vickos U, Ndemazie NB, Camengo Police SM. Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(13): 114657 [DOI: 10.3748/wjg.v32.i13.114657] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i13/114657.htm |
| Number | Citing Articles |
| 1 |
Monika Różycka-Kosmalska, Marcin Kosmalski. Metabolic Health: The Interplay Between NAFLD, MAFLD, MASLD, and Cardiovascular Disease. Life 2026; 16(7) doi: 10.3390/life16071197
|
| 2 |
Edward V Kasparov, Aleksander A Sinyakov, Olga V Smirnova. Letter to the editor: Pathogenetic factors in the development of metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2026; 32(31): 122317 doi: 10.3748/wjg.122317
|